Looks like you’re on the UK site. Choose another location to see content specific to your location

Home Industry News Warfarin ‘better than aspirin to target stroke’

Warfarin ‘better than aspirin to target stroke’

10th August 2007

Elderly people at risk of stroke could lower that risk to a greater extent by taking warfarin rather than aspirin, a new study has concluded.

After studying people aged 75 or over with a risk factor for stroke who were taking one of the two drugs, UK researchers found that those taking warfarin were less than half as likely to suffer a serious event (52 per cent lower risk) as those taking aspirin.

Both groups were analysed for incidences of fatal or disabling stroke, intracranial haemorrhage and clinically significant arterial embolism.

Publishing their findings in the Lancet medical journal, the researchers say that the aspirin group saw 48 serious events – 44 strokes, one intracranial haemorrhage, and three systemic emboli.

In comparison the warfarin group saw half that number ?-21 strokes, two intracranial haemorrhages and one systemic embolus.

Commenting on the findings, Dr Isabel Lee for the Stroke Association said: “Atrial fibrillation is an important risk factor for stroke and is found in 15 per cent of all stroke patients.

“Identifying warfarin as preventative measure for this age group is a welcome step forward in stroke prevention.”

Stroke is currently England and Wales’ third largest killer, with 150,000 people suffering from stroke each year in the UK.

We currently have 9 jobs available in Pharmacy industry, find your perfect one now.

Stay informed

Receive the latest industry news, Tips
and straight to your inbox.